FHB distributes anti-epidemic Chinese medicines donated by Mainland to residents subject to "restriction-testing declarations" (with photos)
******************************************************************************************
The residents who received the anti-epidemic Chinese medicines come from the following residential buildings:
- Tak Sui House, Tak Long Estate, Kowloon City
- Heng Chi House, Tin Heng Estate, Yuen Long
- Heng Fu House, Tin Heng Estate, Yuen Long
- Heng Kin House, Tin Heng Estate, Yuen Long
- Pok Man House, Pok Hong Estate, Sha Tin
- Shun Wo House, Wo Che Estate, Sha Tin
- Chun Hin House, Ching Chun Court, Tsing Yi
- Chun Ho House, Ching Chun Court, Tsing Yi
- Fuk Yat House, Yat Tung (I) Estate, Tung Chung
- Yu Yat House, Yat Tung (I) Estate, Tung Chung
- Kit Yat House, Yat Tung (II) Estate, Tung Chung
- Sau Yin House, Sau Mau Ping Estate, Kwun Tong
- Shing Tai House, On Tai Estate, Kwun Tong
The FHB expresses its heartfelt gratitude to the Central People's Government for its ceaseless support to Hong Kong's anti-epidemic work in co-ordinating the delivery of anti-epidemic pCms to Hong Kong within a short timeframe. The move assisted Hong Kong in the fight against the fifth wave of the epidemic and demonstrated the deepest care extended by the Central People's Government to the people of Hong Kong. The FHB also appreciated the efforts of the relevant government departments conducting the operations of "restriction-testing declaration" for their assistance in distributing the anti-epidemic pCms. The Government will continue to distribute the pCms concerned through different channels (including Community Isolation Facilities).
Apart from the first batch of "Lianhua Qingwen Jiaonang" and "Jinhua Qinggan Keli" delivered to Hong Kong, another pCm, namely "Huoxiang Zhengqi", will also arrive Hong Kong by phases. The three pCms aforementioned are recommended in the Mainland's "Diagnosis and Treatment Protocols for Novel Coronavirus Pneumonia", and widely applied in the anti-epidemic work in the Mainland. Under clinical guidance of Chinese medicine practitioners (CMPs), the relevant pCm could be used during the stage of medical surveillance, and treatment for patients with mild and common symptoms, subject to actual clinical conditions.
Different Chinese medicines are suitable for use having regard to the physique, cause of disease and medical conditions of different people. With a view to safeguarding health and medication safety, members of the public should seek professional advice from CMPs before consuming Chinese medicines.
Chinese medicine is an integral part of Hong Kong's healthcare system. The Government will continue to engage the Chinese medicine sector and the Hospital Authority to further explore the way forward in supporting members of the public affected by the epidemic, including those under/pending quarantine and isolation, with a view to allowing Chinese medicine to give full play to its strengths and effects to a greater extent in the entire process of anti-epidemic and treatment efforts.
Ends/Tuesday, March 1, 2022
Issued at HKT 21:50
Issued at HKT 21:50
NNNN
Photo
